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OBJECTIVES: Conﬂicting evidence exists regarding whether
very short recall periods are required for making valid judgments
about the effectiveness of health care interventions. This analy-
sis explored the inﬂuence of two factors thought to impact recall,
recency and signiﬁcance of events, on caregiver recall of symp-
toms of infant gastroesophageal reﬂux disease (GERD).
METHODS: Retrospective analyses were conducted on 185
infants with GERD from a multi-national validation study of 
the Revised Infant-Gastroesophageal Reﬂux Questionnaire (I-
GERG-R), a measure of symptom severity. Primary caregivers
completed a 12-item I-GERQ-R weekly and a 5-item diary daily
during the three-week study period. Due to word limitations, this
abstract only reports results from the ‘frequency of spit-up’ item
during the ﬁrst week. RESULTS: Overall, a moderately high
Pearson correlation (r = 0.636) was observed between the diary
and the I-GERQ-R item. When the open-ended diary responses
were recoded into the same structured format as the I-GERQ-R
item, the correlation improved signiﬁcantly (r = 0.829), indicat-
ing that initial moderate correlation was largely due to the dif-
ferent response format rather than recall bias. The correlations
between the I-GERQ-R item and the average of the diary item
were about equal between the last two days and the ﬁrst two
days of the ﬁrst week (original: r = 0.585 and 0.589; recoded: r
= 0.758 and 0.745), indicating that the I-GERQ-R response was
not largely inﬂuenced by the most recent 2-day experience. The
correlations between the I-GERQ-R item and the diary item on
the day with the largest number of reported spit-ups were not
larger than that between I-GERQ-R and the average diary score
of other 6 days (original: r = 0.627 and 0.630; recoded: 0.767
and 0.821), indicating that I-GERQ-R was not largely inﬂuenced
by the most symptomatic day. CONCLUSION: Overall, we
found that recency and high frequency of the event did not
unduly inﬂuence parent’s recall of infant GERD symptoms.
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OBJECTIVES: Assess health-related quality of life (HRQOL)
among patients with gastroesophageal reﬂux disease (GERD)
who have frequent symptoms considered atypical for GERD.
METHODS: A sample of US adults participated in a web survey
including the GERD Symptom & Medication Questionnaire
(GERD-SMQ), a validated GERD screener. Frequency of atypi-
cal symptoms (globus, sinusitis, dry coughing, throat clearing,
sore throat, snoring, wheezing, choking, non-cardiac chest pain,
and hoarseness) during the previous 3 months were assessed. Fre-
quent symptoms were deﬁned as ≥ 2 days/nights per week with
each symptom. SF-36 Mental Component Summary (MCS) and
Physical Component Summary (PCS) scores were calculated and
mean differences were compared for respondents with GERD
and atypical symptoms vs. those with GERD but without atypi-
cal symptoms. Bonferroni correction was used to adjust for mul-
tiple comparisons testing. Lower scores signiﬁed worse HRQOL;
differences of 2 or more points are generally considered clinically
signiﬁcant. RESULTS: A total of 2805 of 18,213 invited to par-
ticipate responded. 2603 satisﬁed the study criteria; 701 were
individuals with GERD. Overall, 74% and 66% of individuals
with GERD reported at least one nighttime or daytime atypical
symptom, respectively. Mean MCS and PCS scores among
GERD cases were signiﬁcantly lower among those with vs.
without each nighttime atypical symptom (P < 0.007 for all
nighttime atypical symptoms). Similar reductions in mean MCS
and PCS were seen among GERD cases with daytime atypical
symptoms when compared to those without each daytime
symptom (P < 0.0056 for all). Mean MCS and PCS scores were
4–10 points lower among GERD cases with atypical symptoms
compared with GERD cases without atypical symptoms. CON-
CLUSION: Nighttime and daytime atypical symptoms were
associated with signiﬁcantly lower HRQOL scores. Among
GERD patients, there may be an incremental negative impact of
atypical symptoms on mental and physical functioning. Clini-
cians should determine the presence of atypical symptoms in an
effort to improve HRQOL in patients with GERD.
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OBJECTIVES: The decision to perform cholecystectomy in case
of gallstones is based on a trade-off between the costs and risks
of treatment related complications at the one hand and the mor-
tality and morbidity associated with gallstones on the other
hand. An adequate instrument for treatment planning, outcome
monitoring, and clinical trials of patients with gallstone-related
symptoms is therefore crucial. The Gastrointestinal Quality of
Life Index (GIQLI) questionnaire has previously been validated
for various gastrointestinal disorders. The purpose of the present
study was to validate the Swedish translation of GIQLI speciﬁ-
cally for gallstone disease. METHODS: GIQLI was translated to
Swedish and re-translated back to German for linguistic control.
Responsiveness was tested in 187 consecutive patients who
underwent planned cholecystectomy. Internal consistency and
test-retest stability 12 and 15 months after surgery was tested on
the same sample. Construct validity was assessed by comparing
the GIQLI score with the bodily pain scale of SF-36 and four
single-item questions regarding pain frequency, pain localisation,
the patient’s own conviction of the origin of pain, and a VAS-
scale in x consecutive patients. RESULTS: No major deviation
was found between the original questionnaire and the re-
translated version. A high responsiveness was seen, with GIQLI
score increasing from 95.1 (SD 24.8) to 111.8 (SD 20.1) six
months after surgery (p < 0.001). The GIQLI score correlated
signiﬁcantly with all other measures of gallstone-related symp-
toms except a question regarding the patient’s own conviction of
the origin of the symptoms. There was a high test-retest stabil-
